Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study. [electronic resource]
Producer: 20030619Description: 2138-46 p. digitalISSN:- 0732-183X
- Adolescent
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Benzamides
- Cross-Over Studies
- Cytarabine -- administration & dosage
- Female
- Humans
- Imatinib Mesylate
- Interferon-alpha -- administration & dosage
- Leukemia, Myeloid, Chronic-Phase -- drug therapy
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Piperazines -- adverse effects
- Prospective Studies
- Pyrimidines -- adverse effects
- Quality of Life
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.